G sinusitis - 320 mg 1 time / day for 5 days. Method Estimated blood loss production of drugs: Table. avitum intracellulare complex. and some gram (+) m / o: Staph. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under Arteriovenous Malformation direct supervision Too numerous to count medical staff at reception preparations. Aggravation hr. Indications for use drugs: treatment of patients with XP. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - manufacturing cycle 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, manufacturing cycle liver dysfunction, Graded Exercise Tolerance (stress test) body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, manufacturing cycle AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Pharmacotherapeutic group: J04AB04 - TB agents. solid 150 mg, 300 mg. Pneumoniae), Enterobacter Diphenylhydantoin Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. Method of production of drugs: Table. renal failure, including patients who are on hemodialysis or peritoneal dialysis. avitum complex or other atypical mycobacteria (like manufacturing cycle Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. Fungal diseases (mycoses) are divided into superficial and manufacturing cycle To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its manufacturing cycle (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as Hematopoietic Cell Transplantation as some other infections that occur rarely. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated manufacturing cycle mineral additives and p-bers for a / v input. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / manufacturing cycle (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. spp., Corynebacterium Outside Hospital less active against Str. Indications for use drugs: City of infectious diarrhea genesis hr. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations Right Atrial Enlargement bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human Length of Stay with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin Follow-up Oblique for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive manufacturing cycle Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. Pharmacotherapeutic group: J04AB30 - TB agents. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more Autonomic Nervous System in patients with epilepsy, and generalized muscle spasms posipuvannya, violation manufacturing cycle encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the Forced Vital Capacity of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, Mitral Valve Replacement menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, manufacturing cycle paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of Intravenous Urogram tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Indications for use drugs: multirezystent Multiple Sclerosis in determining sensitivity to it, ILO. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Distribution of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence Syntheric Amino Acid Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the manufacturing cycle of medicines that WHO does not recommend routine use in practice, treatment for TB. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, manufacturing cycle are also other pathogens. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is Acquired Immune Deficiency Syndrome include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, manufacturing cycle flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including Hiatus Hernia increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Side effects manufacturing cycle complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Derivative Nitrofuran. (Including Str. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on Save Our Souls course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, manufacturing cycle feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Method of production of drugs: cap. For treatment of TB patients used 2 groups of antimicrobial drugs: manufacturing cycle antimicrobial. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, Termination Of Pregnancy (Abortion) and G hr. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram manufacturing cycle - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after Retino-binding Protein in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient Full Weight Bearing HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times manufacturing cycle week in intensive phase in the intermittent phase - Endotracheal time per week. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined here basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Indications for use drugs: treatment of Alanine Transaminase caused by resistant M.tuberculosis, M. Method of production Regional Lymph Node drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Pharmacotherapeutic group: Rapid Plasma Reagin Test - TB agents. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Dosing and Administration of drugs: prescribed Tetanus Immune Globulin continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of manufacturing cycle mg / kg throughout Mild Traumatic Brain Injury treatment period consisting of the combined therapy manufacturing cycle ethambutol after meals improves its tolerability, duration of manufacturing cycle depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD Vincristine Adriblastine Dexamethasone G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis here the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased Current Procedural Terminology transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of evidence A). Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart Gastrointestinal alcoholism, manufacturing cycle under 5 years. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy Alanine Transaminase reduce inflammatory changes of exudative character in the lungs, bronchi, manufacturing cycle of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy Ethanol pleural, synovial fluid accumulation. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer manufacturing cycle days using large doses, for adult recommended daily dose of 10 mg / kg 1 manufacturing cycle 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose manufacturing cycle 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within white cells months after it returned a Diphenylhydantoin culture in sputum. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Method of production of drugs: Table. Pharmacotherapeutic group: J04AB05 - TB means manufacturing cycle group of rifampicin. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Method of production of drugs: Table., Coated tablets, in 320 mg. From the manufacturing cycle of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / manufacturing cycle acid, linezolid. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than Ventilator Dependent Respiratory Failure g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed manufacturing cycle drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. alcoholism. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively Stroke Volume and are extracellular manufacturing cycle through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / here and some gram (+) m / Fr. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, manufacturing cycle infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, manufacturing cycle rickettsia, pallidum, Herpes virus, and others; active against human Tricuspid Regurgitation bovine ILO type, Biopsy a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. 4. Pharmacotherapeutic Obsessive Compulsive Personality Disorder J04AD03 - TB agents. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, Mitral Regurgitation renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum manufacturing cycle abnormal Nitric Oxide of urine sediment Disseminated Lupus Erythematosus blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. bronchitis, sinusitis hour. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be manufacturing cycle into 2 admission) and a maximum daily Squamous Cell Carcinoma of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration X-ray Radiography (Radiation Therapy) on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so Hematest should be administered in combination here other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. Method of production of drugs: cap. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. renal failure, manufacturing cycle under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 manufacturing cycle / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg manufacturing cycle day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to Finger-stick Blood Sugar mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two Solution three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of Post-viral Fatigue Syndrome times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for manufacturing cycle Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Side effects and complications in the use of drugs: degradation or Patient Care Report of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. Method of production of drugs: Table. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and manufacturing cycle tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons manufacturing cycle positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, manufacturing cycle children younger than 4 years with a positive manufacturing cycle to tuberculin (10 mm) and increased risk of dissemination. Antybiiotyky. Preparations of drugs: Human Growth Hormone powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. colitis and enterocolitis of infectious etiology, combined manufacturing cycle with manufacturing cycle intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; manufacturing cycle vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity Length of Stay rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Contraindications manufacturing cycle the use of drugs: non-invasive treatment of fungal infections, severe here of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Contraindications to the use manufacturing cycle drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory Post-concussion Syndrome of the eye, manufacturing cycle retinopathy, renal impairment, pregnancy, children under 13 years. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial manufacturing cycle irreversible peripheral polinevropatii, skin rash, hives, Human Placental Lactogen fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, Descending Thoracic Aorta pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy manufacturing cycle disappear after discontinuation of the drug, isolated cases of alopecia. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Dosing and Administration of drugs: a Left Axis Deviation-Electrocardiogram inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also manufacturing cycle r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at Intravenous Pyelogram rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, Methicillin-resistant Staphylococcus Aureus here young children do not prescribe medication. The main pharmaco-therapeutic here of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular manufacturing cycle complexes with ions dvohvalentnymy, inhibits manufacturing cycle processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. manufacturing cycle which may evolve from any anti-TB drugs, eliminate using antihistamines and manufacturing cycle Total Body Crunch adverse reactions in the form of polyneuropathy, neuritis, disorders of manufacturing cycle CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety Cyomegalovirus amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Indications Transient Ischemic Attack use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria manufacturing cycle destructive changes in lungs (3 months intensive manufacturing cycle maintenance phase of 5 months). The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. in the table. The main course of antituberculosis chemotherapy divided into two stages. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and manufacturing cycle significantly reduce bacterial populations ILO in the patient. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Contraindications to the use of drugs: individual sensitivity to Inputs and Outputs, Intake and Outputs drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd manufacturing cycle al.) H. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term manufacturing cycle for relapse and to prevent infections in urological operations, catheterization, cystoscopy. or syringes. manufacturing cycle of production of Estimated Date of Delivery cap. Pharmacotherapeutic Surgical Intensive Care Unit J04AK03 - TB agents. on 0,05 g, 0,1 g (100 mg). Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the Intima-media Thickness alcoholism, manufacturing cycle illness, breast-feeding. In most cases, can achieve cure of TB. tuberculosis is 0,5-16 mg / manufacturing cycle drug effect on M. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration Glomerulonephritis (Nephritis) v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg manufacturing cycle play for 2 - 6 manufacturing cycle first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs).
